Your browser doesn't support javascript.
loading
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Oaknin, Ana; Friedman, Claire F; Roman, Lynda D; D'Souza, Anishka; Brana, Irene; Bidard, François-Clement; Goldman, Jonathan; Alvarez, Edwin A; Boni, Valentina; ElNaggar, Adam C; Passalacqua, Rodolfo; Do, Khanh T M; Santin, Alessandro D; Keyvanjah, Kiana; Xu, Feng; Eli, Lisa D; Lalani, Alshad S; Bryce, Richard P; Hyman, David M; Meric-Bernstam, Funda; Solit, David B; Monk, Bradley J.
Afiliación
  • Oaknin A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Roman LD; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • D'Souza A; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Brana I; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Bidard FC; Institut Curie, St Cloud, France.
  • Goldman J; The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Alvarez EA; University of California, San Francisco, CA, USA.
  • Boni V; START Madrid Centro Oncologico Clara Campal (CIOCC), Madrid, Spain.
  • ElNaggar AC; West Cancer Center and Research Institute, Memphis, TN, USA.
  • Passalacqua R; Oncologia Medica-ASST Istituti Ospitalieri Cremona, Cremona, Italy.
  • Do KTM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Santin AD; Yale School of Medicine, New Haven, CT, USA.
  • Keyvanjah K; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Xu F; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Eli LD; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Lalani AS; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Bryce RP; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA. Electronic address: bradley.monk@usoncology.com.
Gynecol Oncol ; 159(1): 150-156, 2020 10.
Article en En | MEDLINE | ID: mdl-32723675
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias del Cuello Uterino / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias del Cuello Uterino / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article País de afiliación: España